(Intervention) Recommending HPV vaccine for patients 9-10 years of age for Human Papillomavirus

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
Human Papillomavirus(Intervention) Recommending HPV vaccine for patients 9-10 years of age - Behavioral
Eligibility
18+
All Sexes
What conditions do you have?
Select

Study Summary

This trial will test whether earlier vaccination for HPV will result in less parental refusal and higher rates of full vaccination.

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

1 Primary · 2 Secondary · Reporting Duration: post-intervention assessed in year 5 of study, year 4 of trial

Year 5
Age at completion of two dose HPV series
Age at initiation of the HPV series
HPV completion by age 13 years

Trial Safety

Trial Design

2 Treatment Groups

Providers recommending HPV vaccine at age 11-12 years of age
1 of 2
Providers recommending HPV vaccine at age 9-10 years of age
1 of 2

Active Control

Experimental Treatment

660 Total Participants · 2 Treatment Groups

Primary Treatment: (Intervention) Recommending HPV vaccine for patients 9-10 years of age · No Placebo Group · N/A

Providers recommending HPV vaccine at age 9-10 years of age
Behavioral
Experimental Group · 1 Intervention: (Intervention) Recommending HPV vaccine for patients 9-10 years of age · Intervention Types: Behavioral
Providers recommending HPV vaccine at age 11-12 years of age
Behavioral
ActiveComparator Group · 1 Intervention: (Control) Recommending HPV vaccine for patients 11-12 years of age · Intervention Types: Behavioral

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: post-intervention assessed in year 5 of study, year 4 of trial

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor
1,593 Previous Clinical Trials
1,926,906 Total Patients Enrolled
National Cancer Institute (NCI)NIH
13,077 Previous Clinical Trials
41,138,968 Total Patients Enrolled
National Institutes of Health (NIH)NIH
2,442 Previous Clinical Trials
24,579,831 Total Patients Enrolled
Allison Kempe, MD, MPHPrincipal InvestigatorUniversity of Colorado, Denver
11 Previous Clinical Trials
517,125 Total Patients Enrolled

Eligibility Criteria

Age 18+ · All Participants · 4 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
The practice is located in Metro Denver, Colorado and Metro Los Angeles, California.
Practices do not currently recommend HPV vaccination at 9-10 years.